vs
Side-by-side financial comparison of Maase Inc. (MAAS) and Precipio, Inc. (PRPO). Click either name above to swap in a different company.
Maase Inc. is the larger business by last-quarter revenue ($9.9M vs $6.8M, roughly 1.5× Precipio, Inc.). Precipio, Inc. produced more free cash flow last quarter ($291.0K vs $-18.3M).
Precipio, Inc. is a specialty diagnostic firm that develops and provides advanced oncology, genetic, and rare disease testing solutions. It primarily serves healthcare providers, clinical laboratories, and patients across the United States, with a core focus on enhancing diagnostic accuracy and improving patient health outcomes.
MAAS vs PRPO — Head-to-Head
Income Statement — Q2 FY2023 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $9.9M | $6.8M |
| Net Profit | — | $526.0K |
| Gross Margin | 78.7% | 45.9% |
| Operating Margin | -55.9% | 7.9% |
| Net Margin | — | 7.7% |
| Revenue YoY | — | 28.4% |
| Net Profit YoY | — | 244.1% |
| EPS (diluted) | — | $0.36 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $6.8M | ||
| Q3 25 | — | $6.9M | ||
| Q2 25 | — | $5.6M | ||
| Q1 25 | — | $4.9M | ||
| Q4 24 | — | $5.3M | ||
| Q3 24 | — | $5.3M | ||
| Q2 24 | — | $4.5M | ||
| Q1 24 | — | $3.5M |
| Q4 25 | — | $526.0K | ||
| Q3 25 | — | $-79.0K | ||
| Q2 25 | — | $74.0K | ||
| Q1 25 | — | $-884.0K | ||
| Q4 24 | — | $-365.0K | ||
| Q3 24 | — | $-626.0K | ||
| Q2 24 | — | $-1.2M | ||
| Q1 24 | — | $-2.1M |
| Q4 25 | — | 45.9% | ||
| Q3 25 | — | 43.6% | ||
| Q2 25 | — | 43.2% | ||
| Q1 25 | — | 43.6% | ||
| Q4 24 | — | 49.8% | ||
| Q3 24 | — | 43.1% | ||
| Q2 24 | — | 38.1% | ||
| Q1 24 | — | 26.5% |
| Q4 25 | — | 7.9% | ||
| Q3 25 | — | -0.9% | ||
| Q2 25 | — | -14.6% | ||
| Q1 25 | — | -17.5% | ||
| Q4 24 | — | -6.3% | ||
| Q3 24 | — | -11.3% | ||
| Q2 24 | — | -26.8% | ||
| Q1 24 | — | -59.6% |
| Q4 25 | — | 7.7% | ||
| Q3 25 | — | -1.1% | ||
| Q2 25 | — | 1.3% | ||
| Q1 25 | — | -18.0% | ||
| Q4 24 | — | -6.9% | ||
| Q3 24 | — | -11.9% | ||
| Q2 24 | — | -27.1% | ||
| Q1 24 | — | -59.8% |
| Q4 25 | — | $0.36 | ||
| Q3 25 | — | $-0.05 | ||
| Q2 25 | — | $0.05 | ||
| Q1 25 | — | $-0.59 | ||
| Q4 24 | — | $-0.22 | ||
| Q3 24 | — | $-0.42 | ||
| Q2 24 | — | $-0.83 | ||
| Q1 24 | — | $-1.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $10.9M | $2.7M |
| Total DebtLower is stronger | — | $83.0K |
| Stockholders' EquityBook value | $31.6M | $14.6M |
| Total Assets | $47.0M | $21.3M |
| Debt / EquityLower = less leverage | — | 0.01× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $2.7M | ||
| Q3 25 | — | $2.3M | ||
| Q2 25 | — | $1.1M | ||
| Q1 25 | — | $1.0M | ||
| Q4 24 | — | $1.4M | ||
| Q3 24 | — | $1.1M | ||
| Q2 24 | — | $1.3M | ||
| Q1 24 | — | $776.0K |
| Q4 25 | — | $83.0K | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $383.0K | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $14.6M | ||
| Q3 25 | — | $13.7M | ||
| Q2 25 | — | $12.3M | ||
| Q1 25 | — | $11.7M | ||
| Q4 24 | — | $12.1M | ||
| Q3 24 | — | $11.9M | ||
| Q2 24 | — | $12.1M | ||
| Q1 24 | — | $12.8M |
| Q4 25 | — | $21.3M | ||
| Q3 25 | — | $21.2M | ||
| Q2 25 | — | $18.8M | ||
| Q1 25 | — | $17.8M | ||
| Q4 24 | — | $17.0M | ||
| Q3 24 | — | $17.0M | ||
| Q2 24 | — | $17.3M | ||
| Q1 24 | — | $16.6M |
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.03× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.2M | $366.0K |
| Free Cash FlowOCF − Capex | $-18.3M | $291.0K |
| FCF MarginFCF / Revenue | -184.4% | 4.3% |
| Capex IntensityCapex / Revenue | 1.0% | 1.1% |
| Cash ConversionOCF / Net Profit | — | 0.70× |
| TTM Free Cash FlowTrailing 4 quarters | — | $359.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $366.0K | ||
| Q3 25 | — | $10.0K | ||
| Q2 25 | — | $353.0K | ||
| Q1 25 | — | $-44.0K | ||
| Q4 24 | — | $565.0K | ||
| Q3 24 | — | $41.0K | ||
| Q2 24 | — | $500.0K | ||
| Q1 24 | — | $-667.0K |
| Q4 25 | — | $291.0K | ||
| Q3 25 | — | $-44.0K | ||
| Q2 25 | — | $294.0K | ||
| Q1 25 | — | $-182.0K | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-68.0K | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 4.3% | ||
| Q3 25 | — | -0.6% | ||
| Q2 25 | — | 5.2% | ||
| Q1 25 | — | -3.7% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -1.3% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 1.1% | ||
| Q3 25 | — | 0.8% | ||
| Q2 25 | — | 1.0% | ||
| Q1 25 | — | 2.8% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.1% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 0.70× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 4.77× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MAAS
| Wealth management | $7.8M | 78% |
| Insurance consulting | $1.0M | 10% |
| Other | $975.0K | 10% |
| Asset management | $168.0K | 2% |
PRPO
Segment breakdown not available.
